Literature DB >> 11231039

Role of nitric oxide on atrial natriuretic peptide release induced by angiotensin II in superfused rat atrial tissue.

H Soualmia1, C Barthélemy, J Eurin, F Masson, A Carayon.   

Abstract

The present study investigated the role of nitric oxide (NO) on atrial natriuretic peptide (ANP) release stimulated by angiotensin II (Ang II) (10(-7) M) in superfused sliced rat atrial tissue. The use of N(G)-nitro-L-arginine methyl ester (L-NAME) at 10(-4) M, an inhibitor of nitric oxide synthase did not modify basal ANP release. In presence of Ang II (10(-7) M), we observed that L-NAME enhanced ANP secretion induced by Ang II. Furthermore, cGMP levels increased significantly in the presence of Ang II and was attenuated by L-NAME. On the other hand, the perfusion of 8 bromo-cGMP (10(-5) M) with Ang II reduced the effect of this octapeptide on ANP secretion. Secondly, we evaluated the effect of authentic NO on ANP release and observed that perfusion of NO reduced significantly the effect of Ang II on ANP release. We propose that the effect of Ang II on ANP secretion was modulated by NO likely via cGMP pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231039     DOI: 10.1016/s0167-0115(00)00237-8

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  1 in total

1.  Efficacy of continuous low-dose human atrial natriuretic peptide given from the beginning of cardiopulmonary bypass for thoracic aortic surgery.

Authors:  Akira Sezai; Motomi Shiono; Mitsumasa Hata; Mitsuru Iida; Shinji Wakui; Masao Soeda; Nanao Negishi; Yuji Kasamaki; Satoshi Saito; Jitsu Kato; Yukiyasu Sezai
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.